Effect of sildenafil in primary pulmonary hypertension
Pakistan Journal of Medical Sciences. 2007; 23 (2): 264-266
em Inglês
| IMEMR
| ID: emr-84797
ABSTRACT
Primary pulmonary hypertension is a disorder with limited treatment options and poor outcome. We demonstrated a beneficial role of sildenafil, a phosphodiesterase 5 inhibitor, in a patient with primary pulmonary hypertension. After the initiation of sildenafil the pulmonary artery pressure decreased from 40/20mmHg to 16/6mmHg, while mean pulmonary arterial systolic pressure decreased from 25mmHg to 10mmHg. Sildenafil has a beneficial effect in patients with primary pulmonary hypertension in improving the functional class and decreasing the pulmonary artery pressures
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Resultado do Tratamento
/
Hipertensão Pulmonar
Tipo de estudo:
Relato de Casos
Limite:
Feminino
/
Humanos
Idioma:
Inglês
Revista:
Pak. J. Med. Sci.
Ano de publicação:
2007
Similares
MEDLINE
...
LILACS
LIS